• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Ironwood Pharmaceuticals, Inc. (IRWD)

    -NasdaqGS
    14.67 0.87(6.30%) Dec 17, 4:00PM EST
    Add to Portfolio
    Prev Close:13.80
    Open:13.77
    Bid:0.01 x 100
    Ask:2,000.00 x 100
    1y Target Est:14.12
    Beta:1.61
    Earnings Date:Jan 19 - Jan 23 (Est.)
    Day's Range:13.71 - 14.69
    52wk Range:9.01 - 15.95
    Volume:717,900
    Avg Vol (3m):1,013,250
    Market Cap:2.05B
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IRWD

    Comparison

    Symbol% ChgMkt Cap
    IRWDUp 6.30%2.05B
    SHPG42.16B
    SCMP587.86M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):44.41
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.33
    Quarterly EPS Est (Dec-14) :-0.20
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):-0.58

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company’s lead product candidate, linaclotide, a guanylate cyclase type-C agonist for irritable... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback